Concepedia

Nazanin Majd

NM

Statistics

Publications

17

Citations

669

H-Index

12

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Cincinnati Medical Center

Harvard University

Baylor College of Medicine

Beth Israel Deaconess Medical Center

Nazanin Majd is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2005–2025

17

Publications

17

IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma

Satoshi Kofuji, Akiyoshi Hirayama, Alexander Otto Eberhardt et al. · Nature Cell Biology · 2019 · 170 citations · Full text

, , +7

The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis

Kazutaka Sumita, Yu-Hua Lo, Koh Takeuchi et al. · Molecular Cell · 2016 · 82 citations · Full text

, , +11

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

Nazanin Majd, Steven G. Waguespack, Filip Jankú et al. · Journal for ImmunoTherapy of Cancer · 2020 · 71 citations · Full text

A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma

John de Groot, Martina Ott, Jun Wei et al. · CNS Oncology · 2022 · 68 citations · Full text

Inhibition of neuronal apoptosis by the cyclin‐dependent kinase inhibitor GW8510: Identification of 3′ substituted indolones as a scaffold for the development of neuroprotective drugs

Kyle Johnson, Li Liu, Nazanin Majd et al. · Journal of Neurochemistry · 2005 · 57 citations

1–5 of 17